Form 4: Lexaria Bioscience Corp. Director Nicholas W. Baxter Reports Transaction
SEC Form 4 Filing
Director Nicholas W. Baxter reports a transaction involving Lexaria Bioscience Corp. common shares and stock options.
Summary
- On July 26, 2024, Nicholas W. Baxter, a director of Lexaria Bioscience Corp., reported a transaction.
- The transaction involved the disposition of 11,000 common shares.
- Baxter also acquired 12,000 stock options with an exercise price of $3.39, exercisable from July 26, 2024, and expiring on July 26, 2029.
- Following the reported transactions, Baxter directly owns 52,000 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a transaction by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Key Dates
| Date | Description |
|---|---|
| 04/26/2021 | Date stock options were granted, exercisable until 04/26/2026, repriced from $5.31 pursuant to shareholder approval received May 9, 2023 |
| 06/08/2021 | Date stock options were granted, exercisable until 06/08/2026, repriced from $7.08 pursuant to shareholder approval received May 9, 2023 |
| 09/01/2021 | Date stock options were granted, exercisable until 09/01/2026, repriced from $6.23 pursuant to shareholder approval received May 9, 2023 |
| 03/08/2022 | Date stock options were granted, exercisable until 03/08/2027 |
| 10/12/2022 | Date stock options were granted, exercisable until 10/12/2027 |
| 05/09/2023 | Shareholder approval received for repricing of stock options |
| 07/25/2023 | Date stock options were granted, exercisable until 07/25/2028 |
| 04/26/2024 | Date stock options were granted, exercisable until 04/26/2029 |
| 07/26/2024 | Date of transaction: disposition of common shares and acquisition of stock options; stock options exercisable until 07/26/2029 |
| 07/30/2024 | Date of signature |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.